News | April 28, 2022
Thermo Fisher Scientific expands R&D facility in Hyderabad
This facility will design & develop instruments, perform product reliability performance testing and verification
This facility will design & develop instruments, perform product reliability performance testing and verification
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
The business is a recognized leader in managing Covid-19 and mRNA research programs
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Support for biologics manufacturability and Industry 4.0 initiatives
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
Subscribe To Our Newsletter & Stay Updated
